ODDB.org: Open Drug Database

Home - 66944 - 01 - 001

Skyrizi 75 mg, lnjektionslösung in einer Fertigspritze - 2

Swissmedic Key	66944001	Registration Holder	AbbVie AG
Name	Skyrizi 75 mg, lnjektionslösung in einer Fertigspritze	Date of registration	18.04.2019
		Introduction of Sequence	18.04.2019
ATC-Classification	Risankizumab (L04AC18)	Revision date
WHO	WHO-DDD	Valid until
Index Therapeuticus (BSV)	07.15.	Show package size	2
Index Therapeuticus (Swissmedic)	07.15.	Description
Swissmedic categorie.	B
SL Eintrag	No	Indication
Information for professionals	IP	Consumer information	CI
Ex-factory-Price	3293.76
Deductible	k.A.	Consumer price	3622.10
Feedback	FB
GTIN	7680669440015	Medication Code	Biotechnologika
Pharmacode		Disponibility

Composition

Lösung: risankizumabum 75.0 mg, sorbitolum 34 mg, dinatrii succinas hexahydricus corresp. natrium 0.149 mg, natrium 0.149 mg, acidum succinicum, polysorbatum 20, aqua ad iniectabile ad solutionem pro 0.83 ml. Tela cum: alcohol isopropylicus.

Packungsbestandteile

Galenic Form

lnjektionslösung

BAG: Active Agent	Dose
Risankizumabum	75 mg

Inactive agents		additional_information
Alcohol Isopropylicus		Tela cum

Galenic Form

lnjektionslösung in einer Fertigspritze

Excipiens

Active Agent	Dose	additional_information
Risankizumabum	75mg / 0.83ml	Lösung

BAG: Active Agent	Dose
Risankizumabum	75 mg

Inactive agents	Dose
Succinic Acid
Dinatrii Succinas Hexahydricus
Sodium	0.149mg / 0.83ml
Polysorbatum 20
Sorbitol	34mg / 0.83ml

Source

Data was imported : 05.01.2024 Swissmedic Registration : Sequence : Product name : Registration owner: : Product group : Index Therapeuticus (BSV) : Medication Code : Date of registration : Valid until : Package number : Show package size : Commercial Form/Unit : Swissmedic categorie. : Active Agents : Composition :

2025	©ywesee GmbH